Plant-based production and characterization of a promising Fc-fusion protein against microgravity-induced bone density loss.
Ontology highlight
ABSTRACT: Microgravity-induced bone loss is a main obstacle for long term space missions as it is difficult to maintain bone mass when loading stimuli is reduced. With a typical bone mineral density loss of 1.5% per month of microgravity exposure, the chances for osteoporosis and fractures may endanger astronauts' health. Parathyroid Hormone or PTH (1-34) is an FDA approved treatment for osteoporosis, and may reverse microgravity-induced bone loss. However, PTH proteins requires refrigeration, daily subcutaneous injection, and have a short shelf-life, limiting its use in a resource-limited environment, like space. In this study, PTH was produced in an Fc-fusion form via transient expression in plants, to improve the circulatory half-life which reduces dosing frequency and to simplify purification if
SUBMITTER: Xiong Y
PROVIDER: S-EPMC9511166 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA